viewCellmid Limited

Cellmid Ltd's Maria Halasz talks revenue at Proactive's CEO Spotlight Session

Cellmid is rapidly expanding its global sales channels for evolis® hair growth products.Find out more when Maria Halasz presents at Proactive's Spotlight CEO Sessions in Sydney, 3 August. Register today!


Cellmid Ltd (ASX:CDY) has entered into a distribution partnership with Colour Collective in the U.S. for the launch of Cellmid’s Advangen evolis® hair growth products.

This provides Cellmid with an accelerated, direct route to U.S. sales channels that have proven successful in Australia and Japan.

The U.S. is the biggest single market for hair loss treatments with combined sales of circa US$3.5 billion annually.

U.S. sales will commence in 2016 through e-commerce channels with distribution to high-end retail and other direct to consumer opportunities to follow.

With the company well on track to achieve its $2 million sales target in Japan, its recent entry into the Australia market and coming entry into the U.S. market – Cellmid’s consumer health business is set to continue its rapid growth.

Find out more from Maria Halasz, managing director, at Proactive's Spotlight CEO Sessions in Sydney in August 2016.

REGISTER HERE, CLICK ON LINK: Sydney Investor Sessions, Wednesday, 3rd August

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Cellmid Limited

Price: 0.11 AUD

Market: ASX
Market Cap: $13.78 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...



Cellmid Limited to supply rapid diagnostic tests to help in new pandemic

Cellmid Limited (ASX:CDY) CEO Maria Halasz tells Proactive's Andrew Scott they've signed an agreement to supply rapid diagnostic tests (RDT), with products expected to arrive in the country by early April. The test uses a virus-specific detection method that delivers results anywhere between...

on 30/3/20

2 min read